Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. Published in Cell Reports Medicine, a team of researchers from the ...

Lateral flow tests have transformed global healthcare by enabling rapid disease detection and improving access to medical diagnostics. However, their widespread, single-use design is creating an ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...